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Article

Diagnostic Accuracy of Cystatin C–Based eGFR
Equations at Different GFR Levels in Children
Ajay P. Sharma,* Abeer Yasin,* Amit X. Garg,† and Guido Filler*

Summary
Background and objectives The diagnostic accuracy of cystatin C estimated GFR (eGFR) by various cystatin
C equations have varied in different studies. We hypothesized that the GFR level of enrolled patients affects the diagnostic accuracy of a cystatin C equation.
Design, setting, participants, & measurements We analyzed 240 consecutively enrolled children at a single
Canadian center in a prospective and cross-sectional study. Cystatin C was analyzed with nephelometry,
and cystatin C eGFR was estimated by the equations validated in children. GFR was measured by technetium-99m– diethylene-triamine penta-acetic acid (99mTc DTPA).
Results We compared various cystatin C equations across GFR strata ⬍60, ⬍90, ⱖ135, and ⱖ150 ml/min
per 1.73 m2 for an accurate prediction and appropriate classification of the measured GFR. The CKiD, Zappitelli-CysEq, and Zappitelli-CysCrEq equations had a higher accuracy, estimated by eGFR values within
10% and 30% of the respective 99mTc DTPA, in the GFR categories ⬍60 and ⬍90 ml/min per 1.73 m2,
whereas the Bökenkamp, Bouvet, and Filler equations had a greater accuracy in the GFR categories ⱖ135
and ⱖ150 ml/min per 1.73 m2. The Bouvet, CKiD, Filler, Zappitelli-CysEq, and Zappitelli-CysCrEq equations had a greater sensitivity to classify GFR ⬍60 and ⬍90 ml/min per 1.73 m2, whereas the Bökenkamp
equation had a higher sensitivity for GFR ⱖ135 and ⱖ150 ml/min per 1.73 m2.
Conclusions The diagnostic accuracy of various cystatin C equations varies with GFR. This issue needs consideration while applying these equations in clinical practice and for further research on eGFR equations.
Clin J Am Soc Nephrol 6: 1599 –1608, 2011. doi: 10.2215/CJN.10161110

Introduction
Kidney function typically is measured by GFR. In
clinical practice, it is most frequently estimated using
endogenous surrogate markers. Serum creatinine remains the most widely used endogenous marker. Serum cystatin C is a relatively new endogenous marker
that offers the advantage of a constant production by
all nucleated body cells and its almost entire catabolism at the proximal tubule (1). In clinical studies,
serum cystatin C has been found to be a good marker
for predicting GFR (2–9).
The Kidney Disease Outcomes Quality Initiative
(KDOQI) recommends the use of predictive equations
based on the serum concentrations of these markers
(10). Various predictive equations have been established based on serum cystatin C levels (2– 8). In
children, the validated equations have used serum
cystatin C levels either without serum creatinine (e.g.,
Bökenkamp, Filler, Grubb, and Zapitelli-CysEq equations) (2– 4,6) or with serum creatinine (e.g., Bouvet,
chronic kidney disease in children [CKiD], and Zapitelli-CysCrEq equations) (3,8,11). The rationale of combining serum creatinine and plasma cystatin C originated from the fact that the sources of error for either
www.cjasn.org Vol 6 July, 2011

*Department of
Pediatrics, Division of
Pediatric Nephrology,
Children’s Hospital,
and †Department of
Medicine, Division of
Nephrology; London
Health Science Centre,
University of Western
Ontario, London,
Ontario, Canada
Correspondence:
Dr. Guido Filler,
Children’s Hospital,
London Health
Sciences Centre,
University of Western
Ontario, 800
Commissioner’s Road
East, Room E6-104,
London, Ontario, N6A
5W9 Canada. Phone:
(519)685-8377; Fax:
(519)685-8156; E-mail:
guido.filler@lhsc.on.ca

marker differ. Serum creatinine levels are confounded
by muscle mass and variable tubular secretion, whereas
serum cystatin C has a different volume of distribution
and may vary with the volume status (12).
Various cystatin C equations consistently demonstrate a variance between the measured GFR and
cystatin C estimated GFR (eGFR) in the magnitude of
20% to 30% (2,3,13). With different equations, the
estimates of cystatin C eGFR also vary for the same
cystatin C level (3,11,14). The equations performed
differently in subsequent studies than in the original
studies (11). The factors contributing to the variability
in the performance of cystatin C equations are not
well understood.
The use of different gold standards for measuring
GFR cannot completely account for the difference in
the estimated and measured GFR (2,3,13). In children,
age and body mass do not significantly affect cystatin
C eGFR (13). The known confounders affecting cystatin C levels such as corticosteroids and thyroid status
cannot explain the variability in the performance of
different cystatin C equations either (3,8,11). Previous
studies have demonstrated that the variance between
cystatin C eGFR and measured GFR increases in the
Copyright © 2011 by the American Society of Nephrology
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high GFR range when compared with that in the low GFR
range (3,13). The cystatin C eGFR estimates by different
equations also show a higher interequation variability at a
higher GFR (14). Any change in the diagnostic accuracy of
various equations at different GFR levels has not been
systematically investigated.
We hypothesized that the diagnostic accuracy of various
cystatin C equations may vary with GFR level. We tested
this hypothesis in children across different GFR categories
with various validated cystatin C equations.

Materials and Methods
The study was approved by the Institutional Review
Board, and written consent was obtained from the parents or legal guardians of the patients. In a prospective
manner, 240 stable children consecutively referred to the
pediatric nephrology clinic in a single tertiary care Canadian center underwent the estimation of serum cystatin C levels and technetium 99m– diethylene-triamine
penta-acetic acid (99mTc DTPA) GFR. We excluded patients
with an acute illness, acute kidney injury, or a thyroid
disorder. We included patients on a low-dose steroid, as
steroid dose up to 2 mg/kg per day does not affect cystatin
C level (15).
Baseline data were collected regarding the date of birth,
date of assessment, weight, height, and body surface area
(BSA). BMI was calculated by the ratio of weight (kg) and
square of height (m). BMI z-scores were calculated from
the age and gender-specific SD published by the US National Center for Health Statistics (16).
Nuclear GFR Estimation
Nuclear GFR was measured using a 99mTc DTPA renal
scan with three-point sampling approach at 2, 3, and 4

hours after injection (17). As per conventional practice,
measured 99mTc DTPA GFR was normalized to a BSA of
1.73 m2, calculated using the Haycock formula (18). To
ensure reliability of 99mTc DTPA measurements, standard
radiochemical and radiopharmaceutical purity were performed on each preparation of 99mTc DTPA. The average
purity, obtained from our radiopharmacy laboratory, was
approximately 99%. 99mTc DTPA has shown to be in good
agreement with inulin and iothalamate clearance (19).
Calculation of the Estimated GFR
Serum cystatin C was measured using an N Latex cystatin C kit (Siemens Healthcare, Mississauga, Canada) on a
Behring BN ProSpec analyzer (Dade Behring, Marburg,
Germany). The detailed method is described elsewhere (6).
The coefficient of variation of serum cystatin C was 3.1% at
1.06 mg/L, 3.5% at 2.04 mg/L, and 6.7% at 5.26 mg/L.
Cystatin C eGFR was calculated using the previously
published Bökenkamp (2), Bouvet (8), CKiD (11), Filler (6),
Grubb (4), and Zappitelli (3) equations. The published
equations are shown in Table 1. While employing the CKiD
equation, we converted enzymatic serum creatinine to isotope dilution mass spectroscopy (IDMS) standardized creatinine as done in the original study (11).
Evaluation of the Estimated GFR
We compared the correlation, bias, precision, and accuracy
of serum cystatin C eGFR with respect to 99mTc DTPA GFR in
the GFR groups of ⬍60, ⬍90, ⱖ135, and ⱖ150 ml/min per
1.73 m2. These cutoffs have been used previously to categorize CKD (5,20), and to define hyperfiltration (21).
We calculated the bias, precision, and accuracy, as recommended by the National Kidney Foundation (10):

Table 1. Published cystatin C– based estimated GFR equations

Equation Name
Equations with serum cystatin C
Bökenkamp et al. (2)
Filler and Lepage (6)
Grubb et al. (4)
Zappitelli et al. (CysEq) (3)

Equation
GFR (ml/min per 1.73 m2) ⫽ 137/serum cystatin C ⫺ 20.4
GFR (ml/min per 1.73 m2) ⫽ 10ˆ(1.962 ⫹ (1.123 ⫻
LOG(1/Cys C))
GFR (ml/min per 1.73 m2) ⫽ 84.69 ⫻ serum cystatin
C⫺1.68 ⫻ 1.384 for age ⬍14 years
GFR (ml/min per 1.73 m2) ⫽ 75.94/关serum cystatin C1.17兴
if renal transplant, ⫻1.2

Equations with serum cystatin C and serum creatinine
Bouvet et al. (8)
关(SCr (M)/96)(⫺0.35 (⫾0.20))兴 䡠 关(serum cystatin C (mg/
L)/1.2)(⫺0.56(⫾0.19))兴 䡠 关(body weight (kg)/
45)(0.30(⫾0.17))兴 䡠 关age (years)/14)(0.40 (⫾0.16))兴.
CKiDa (11)
eGFR⫽ a关height (m)/Scr (mg/dl兴b关1.8/cystatin C (mg/
L)兴c关30/BUN (mg/dl)兴d关emale兴关height/1.4兴f
Zappitelli et al. (CysCrEq) (3)
GFR (ml/min per 1.73 m2) ⫽ (507.76e0.003⫻height)/
(CysC0.635 ⫻ SCr0.547 关mol/L兴)
If renal transplant, ⫻1.165
If spina bifida, ⫻(SCr0.925 关mol/L兴)/40.45
a

We analyzed the CKiD equation with the model that did not include urea. In the original study, the inclusion of urea level in the
equation improved the performance of CKiD equation to some extent as the model without urea had R2 of 69.4% and percentage
of estimated GFR within 30% of measured GFR of 84% which was slightly lower than the respective values of 75% and 87.7%
with the equation with urea (11). BUN, blood urea nitrogen.
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• Bias ⫽ mean difference between 99mTc DTPA GFR and
cystatin C eGFR
• Relative bias ⫽ mean % difference ⫽ 100 ⫻ [(99mTc
DTPA GFR ⫺ cystatin C eGFR)/99mTc DTPA GFR]
• Precision ⫽ SD of bias (an increase in the SD means a
decrease in the precision)
• Relative precision ⫽ SD of relative bias
• Accuracy
⫽ percentage of cystatin C eGFR values within 10 and
30% of the respective 99mTc DTPA GFR measurements
⫽ area under curve (AUC) for the GFR ⬍60, ⬍90, ⱖ135,
and ⱖ150 ml/min per 1.73 m2 (5,20).
Statistical Analyses
Continuous data were tested for normal distribution
using the D’Agostini Pearson omnibus test. Normally distributed data were analyzed using parametric methods
(mean, SD, t test, Pearson correlation). Otherwise, nonparametric methods (median, interquartile range, Wilcoxon matched pairs test, and Spearman rank correlation)
were applied. The agreement between 99mTc DTPA GFR
and cystatin C eGFR was analyzed by Bland and Altman
analysis (22). The AUC, sensitivity, and specificity of cystatin C eGFR for different GFR cutoffs were analyzed by
receiver operating characteristic (ROC) plots using Medcalc software (23). We used GraphPad Prism software,
version 4.02 (GraphPad, Inc., San Diego, CA) and SPSS
version 17 (SPSS, Inc., Chicago, IL) for statistical analysis.

Results
In the study group of 240 patients, median age was 11.7
years (range 2.0 to 17.9 years) and 107 (45%) were girls. The
reasons for GFR measurement included abnormal kidney
morphology (19.5%), glomerulopathies (14.4%), obstructive uropathy (13.4%), reflux nephropathy (13.0%), proteinuria (9.9%), oncologic disease-associated nephropathy
(6.8%), and others (23%).
The percentage error of the eGFR by all of the equations
with respect to the measured GFR is shown in Figure 1. In
the whole group, the correlation coefficient between the
percentage error and measured GFR was significant for all
of the equations.
Patient characteristics in the five GFR groups, GFR ⬍60
(n ⫽ 31), ⬍90 (n ⫽ 74), 90 to 134 (n ⫽ 84), ⱖ135 (n ⫽ 81), and
ⱖ150 (n ⫽ 41) ml/min per 1.73 m2, are shown in Table 2.
These groups were similar with respect to the age, gender,
and number of adolescent patients. BMI z-score was lower
in the GFR ⬍60 and ⬍90 ml/min per 1.73 m2 groups;
however, the proportion of obese patients was evenly distributed among the groups.
Table 3 shows the mean, median, and correlation coefficients of the measured and estimated GFR. The correlation coefficient decreased with all of the equations with the
increase in GFR, except no interval change with the Bouvet
equation across the GFR.
Table 4 shows the Bland and Altman analysis for the
agreement of eGFR by different equations and measured
GFR. As the bias and SD of bias of the equations increased
with GFR, we analyzed the relative (%) bias and relative
SD of bias as recommended (22,24,25). Unlike the bias and
SD of bias, the relative bias and relative SD of bias of the
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equations changed variably with GFR. The diagnostic accuracy of the equations estimated by eGFR values within
10% and 30% of the respective 99mTc DTPA also varied
with GFR. The CKiD, Zappitelli-CysEq, and ZappitelliCysCrEq equations had a higher accuracy in the GFR
categories ⬍60 and ⬍90 ml/min per 1.73 m2 than in the
GFR ⱖ135 and ⱖ150 ml/min per 1.73 m2. The Bökenkamp,
Bouvet, and Filler equations had a greater accuracy in the
GFR categories ⱖ135 and ⱖ150 ml/min per 1.73 m2. The
Grub equation did not have much change in the accuracy
across the GFR categories.
Table 5 shows the area under the ROC curves (AUC),
sensitivity, and specificity of various equations to appropriately categorize the measured GFR. The Bouvet equation had the AUC of 1.0 over all GFR categories, whereas
all other equations had the AUC of 0.97 to 0.99 for GFR
⬍60 and ⬍90 ml/min per 1.73 m2, which decreased to 0.83
to 0.85 for GFR ⱖ135 and ⱖ150 ml/min per 1.73 m2. For
GFR ⬍60 and ⬍90 ml/min per 1.73 m2, the CKiD, Zappitelli-CysEq, and Zappitelli-CysCrEq equations had ⬎90%
sensitivity for categorizing the GFR. For GFR ⱖ135 and
ⱖ150 ml/min per 1.73 m2, the Bökenkamp equation had
⬎90% sensitivity. All of the equations had ⬎90% specificity for GFR ⬍60 ml/min per 1.73 m2. The specificity was
⬎90% for the Bökenkamp, Bouvet, Filler, and Grubb equations at the GFR ⬍90 ml/min per 1.73 m2, for the Bouvet,
CKiD, Zappitelli-CysEq, and Zappitelli-CysCrEq equations at the GFR ⱖ135 ml/min per 1.73 m2, and for the
Bouvet, CKiD, Filler, Zappitelli-CysEq, and ZappitelliCysCrEq equations at the GFR ⱖ150 ml/min per 1.73 m2.

Discussion
The main finding of the study was that the diagnostic
accuracy of various cystatin C equations changed with
GFR. This change in the diagnostic accuracy occurred in
both classifying and predicting the measured GFR. Notably, the pattern of change in the diagnostic accuracy with
GFR varied among the equations. Some equations performed better at a low GFR and others at a high GFR. To
the best of our knowledge, this is the first study that
demonstrated the variation in the diagnostic accuracies of
different cystatin C eGFR equations with GFR. This observation becomes clinically relevant as it can provide insight
into the clinical applicability of the equations at different
GFR levels. It can also explain the variability in the performance of various equations in different studies (3,11,26).
As per standard methodology, we analyzed the diagnostic accuracy of various equations by two methods: first, by
the ability of the equations to classify the measured GFR
appropriately, as tested by the AUC, sensitivity, and specificity; and second, by the accuracy of the equations in
predicting the measured GFR, as tested by the relative bias,
relative SD of bias, and eGFR values within 10% and 30%
of the respective 99mTc DTPA. The equations were compared over the GFR categories ⬍60, ⬍90, ⱖ135, and ⱖ150
ml/min per 1.73 m2, which were consistent with the
KDOQI recommendations on GFR categorization (10), and
also with previous studies testing eGFR equations in decreased GFR and hyperfiltration (5,20,21).
The AUC of all cystatin C equations (with the exception
of the Bouvet equation, which did not change with GFR)
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Figure 1. | Relationship between the percentage errors of different eGFR equations with measured GFR. Percentage error ⫽ (measured
GFR ⫺ eGFR/measured GFR) ⫻ 100. Correlation coefficient between the percent error and measured GFR for equations with only cystatin
C: Bökenkamp: r ⫽ ⫺0.22 (95% confidence interval [CI], ⫺0.34 to ⫺0.10), Filler: r ⫽ ⫺0.48 (95% CI, ⫺0.57 to ⫺0.37), Grubb: r ⫽ 0.23
(95% CI, 0.11 to 0.35), Zappitelli-CysEq: r ⫽ ⫺0.43 (95% CI, ⫺0.53 to ⫺0.32). Correlation coefficient between the percent error and
measured GFR for equations with cystatin C and creatinine: Bouvet: r ⫽ ⫺0.76 (95% CI, ⫺0.81 to ⫺0.70), CKiD: r ⫽ ⫺0.69 (95% CI, ⫺0.75
to ⫺0.62), Zappitelli-CysCrEq: r ⫽ ⫺0.42 (95% CI, ⫺0.51 to ⫺0.31). P ⬍ 0.05 for correlation coefficients with all of the equations.
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Data are presented as mean (SD). GFR was measured by technetium-99m– diethylene-triamine penta-acetic acid (99mTc DTPA) and presented in ml/min per 1.73 m2. Age ⬎10 years
and BMI z-score ⱖ2.0 are reported to identify adolescents and obese patients, respectively. BMI, body mass index.
a
Data are presented as median (interquartile range).

10.61 (4.72)
19 (46.34%)
19 (46.34%)
0
139.2 (27.35)
40.30 (19.61)
0.44 (1.06)
2 (4.8%)
11.40a (6.55 to 14.70)
38 (46.91%)
35 (43.20%)
0
145.0a (117.0 to 162.0)
41.60a (21.60 to 56.35)
0.49 (1.07)
3 (3.7%)
11.70a (6.86 to 15.0)
5 (6%)
11 (13%)
1 (1.19%)
139.8 (26.54)
41.97 (20.37)
0.49 (1.19)
6 (7.14%)
11.70a (7.87 to 16.0)
36 (49%)
30 (41%)
13 (17.56%)
139.0a (121.5 to 162.0)
35.20a (22.98 to 52.03)
0.05a (⫺0.78 to 0.97)
5 (6.7%)
11.51 (4.42)
16 (51.61%)
12 (38.70)
3 (9.67%)
137.4 (24.43)
30.80a (22.00 to 53.00)
⫺0.10 (1.65)
2 (6.4%)
11.65a (6.92 to 15.35)
114 (47.5%)
107 (44.58%)
20 (8.33%)
144.0a (119.0 to 162.0)
41.25a (22.60 to 54.18)
0.3472 (1.22)
18 (7.5%)
Age, years
Age ⬎10 years, %
Girls, %
Renal transplant
Height, cm
Weight, kg
BMI z-score
BMI z-score ⱖ2.0

GFR ⬍60
(n ⫽ 31)
Whole Group
(n ⫽ 240)

Table 2. Patient characteristics in different GFR categories (ml/min per 1.73 m2)

GFR ⬍90
(n ⫽ 74)

GFR 90 to 134
(n ⫽ 84)

GFR ⱖ 135
(n ⫽ 81)

GFR ⱖ 150
(n ⫽ 41)
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decreased from 0.98 to 0.99 for GFR ⬍60 and ⬍90 ml/min
per 1.73 m2 to 0.83 to 0.85 for GFR ⱖ135 and ⱖ150 ml/min
per 1.73 m2. In clinical context, the AUC of 0.90 to 0.99 is
deemed excellent and that of 0.80 to 0.89 indicates good
performance (23). The AUC of an equation combines its
sensitivity and specificity. There was not only a change in
the sensitivities and specificities of the equations with GFR
but also the extent of change varied among the equations.
The CKiD, Zappitelli-CysEq, and Zappitelli-CysCrEq
equations had ⬎90% sensitivity for classifying GFR ⬍60
and ⬍90 ml/min per 1.73 m2, whereas the Bökenkamp
equation had a similar sensitivity for GFR ⱖ135 and ⱖ150
ml/min per 1.73 m2. The specificities of the equations also
varied with GFR.
The diagnostic accuracy of various equations assessed
for an accurate prediction of the measured GFR again
changed variably with GFR, except no interval change for
Grubb’s equation with GFR (10). As the bias of various
equations increased with the GFR, it was important to
understand the implication of this change. A bias of 15
ml/min per 1.73 m2 at a GFR of 30 ml/min per 1.73 m2
would mean a relative (%) bias of 50%, whereas the same
bias at a GFR of 120 ml/min per 1.73 m2 signifies a relative
bias of 12.5%. Therefore, we estimated the relative bias and
SD of bias for all of the equations (22,24). Unlike the bias
and SD of bias, the relative bias and SD of bias of the
equations changed variably across the GFR categories. Furthermore, the diagnostic accuracy of the equations estimated by eGFR values within 10% and 30% of the respective 99mTc DTPA GFR also varied with GFR. The CKiD,
Zappitelli-CysEq, and Zappitelli-CysCrEq equations had a
higher accuracy in the GFR ranges ⬍60 and ⬍90 ml/min
per 1.73 m2, whereas the Bökenkamp, Bouvet, and Filler
equations had greater accuracy in the GFR categories ⱖ135
and ⱖ150 ml/min per 1.73 m2. As an individual’s day-today GFR varies by 17% (27–29), we looked at the equations
with ⬎80% cystatin C eGFR values within 30% of the
measured GFR across different GFR ranges. This cutoff of
accuracy was met by the Zappitelli-CysEq and ZappitelliCysCrEq equations for GFR ⬍60 ml/min per 1.73 m2, by
the CKiD, Zappitelli-CysEq, and Zappitelli-CysCrEq equations for GFR ⬍90 ml/min per 1.73 m2, and by the Bökenkamp, Bouvet, and Filler equations for the GFR ⱖ135 and
ⱖ150 ml/min per 1.73 m2.
There was an apparent discrepancy in the diagnostic
accuracy of eGFR equations in GFR categorization and
GFR prediction. For example, the Bouvet equation had an
excellent AUC and correlation coefficient overall; however,
it had a relatively large relative bias and lower predictive
accuracy in the low GFR range. It is important to consider
that the AUC and sensitivity of an equation depends on the
cutoff points selected for GFR categorization and the equation’s tendency to underestimate or overestimate the GFR.
On the other hand, the accuracy of an equation for GFR
prediction varies by the closeness of an eGFR to the measured GFR, regardless of the equation’s tendency to underestimate or overestimate the measured GFR. This point
was further evident from a higher percentage error of the
Bouvet equation at the low GFR. Unlike other equations,
the Bouvet equation employed a Baysian approach for GFR

CI, confidence interval.

Mean; median
measured GFR
equations with serum cystatin
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq
Correlation coefficient (95% CI)
equations with serum cystatin
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq

C

C

C

C

0.99 (0.99 to 0.99)
0.81 (0.76 to 0.85)
0.82 (0.78 to 0.86)

0.82 (0.78 to 0.86)
0.82 (0.78 to 0.86)
0.80 (0.74 to 0.84)
0.81 (0.76 to 0.85)

108.5; 107.1
89.58; 91.1
92.25; 94.65

140.5; 143.1
110.6 to 111.8
148.4; 141.4
93.92; 93.75

109.7; 112

Whole Group
(n ⫽ 240)

0.99 (0.99 to 0.99)
0.92 (0.84 to 0.96)
0.91 (0.82 to 0.95)

0.88 (0.76 to 0.94)
0.88 (0.76 to 0.94)
0.84 (0.69 to 0.92)
0.87 (0.75 to 0.94)

51.85; 51.3
41.83; 41.3
36.43; 34.6

52.05; 51
45.18; 44
40.56; 36.9
37.29; 35.4

37.26; 37

GFR ⬍60
(n ⫽ 31)

0.99 (0.99 to 0.99)
0.82 (0.72 to 0.88)
0.84 (0.75 to 0.89)

0.84 (0.76 to 0.90)
0.84 (0.76 to 0.90)
0.77 (0.66 to 0.85)
0.83 (0.74 to 0.89)

70.72; 76.45
57.82; 61.4
54.19; 58

81.49; 87.9
66.23; 70.4
68.09; 70.5
56.35; 58.5

59.14; 66

GFR ⬍90
(n ⫽ 74)

0.99 (0.99 to 0.99)
0.40 (0.21 to 0.57)
0.39 (0.19 to 0.56)

0.36 (0.16 to 0.54)
0.45 (0.25 to 0.61)
0.31 (0.11 to 0.49)
0.40 (0.20 to 0.56)

106.6; 106.5
97.03; 94.19
100.8; 96.0

153.6; 145.6
120.1; 113.7
163.2; 150.9
102.4; 96.0

111.4; 110.5

GFR 90 to 134
(n ⫽ 84)

0.99 (0.99 to 0.99)
0.29 (0.07 to 0.48)
0.36 (0.15 to 0.54)

0.42 (0.22 to 0.59)
0.42 (0.22 to 0.59)
0.36 (0.15 to 0.54)
0.42 (0.22 to 0.59)

144.9; 137.7
110.9; 109.6
118.2; 115.6

180.6; 169.9
141.2; 132.5
206.6; 189.2
119.3; 111.5

153.9; 150

GFR ⱖ 135
(n ⫽ 81)

0.99 (0.99 to 0.99)
0.30 (⫺0.01 to 0.56)
0.39 (0.09 to 0.63)

0.43 (0.14 to 0.66)
0.43 (0.14 to 0.66)
0.34 (0.02 to 0.59)
0.43 (0.14 to 0.66)

160.2; 152.9
116.8; 112.3
125.6; 120

191; 179.3
149.5; 139.9
227.9; 202.1
126.7; 118

166.6; 162

GFR ⱖ 150
(n ⫽ 41)

Table 3. GFR levels estimated by various cystatin C equations and correlation coefficients between the estimated GFR and measured GFR across different GFR categories
(ml/min per 1.73 m2)
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Table 4. Bland and Altman analysis for the agreement of technetium-99m– diethylene-triamine penta-acetic acid (99mTc DTPA) GFR
and cystatin C estimated GFR (estimated by various cystatin C equations) across different GFR categories (ml/min per 1.73 m2)

Bias

Whole group
equations with serum cystatin C
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin C
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq
GFR ⬍ 60 ml/min per 1.73 m2
equations with serum cystatin C
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin C
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq
GFR ⬍ 90 ml/min per 1.73 m2
equations with serum cystatin C
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin C
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq
GFR 90 to 134 ml/min per 1.73 m2
equations with serum cystatin C
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin C
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq
GFR ⱖ135 ml/min per 1.73 m2
equations with serum cystatin C
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin C
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq

SD of
Bias

Relative
Bias (%)

Relative
SD of
Bias (%)

95% Limit of
Agreement
for Relative
SD of Bias

Accuracy (%)
Within
10%

30%

⫺30.76
⫺2.70
⫺38.70
15.78

31.45
20.52
59.59
25.67

⫺23.18
2.71
⫺21.07
13.90

31.51
20.53
31.48
20.88

⫺84.95, 38.58
⫺42.94, 37.52
⫺82.79, 40.64
⫺27.01, 54.83

19.17%
37.50%
17.92%
28.75%

55.83%
85.42%
49.58%
80.83%

1.17
20.12
17.45

10.28
24.07
22.49

⫺3.53
16.08
15.77

16.81
21.72
18.78

⫺36.48, 29.41
⫺26.49, 58.66
⫺21.03, 52.58

27.08%
26.67%
29.58%

79.58%
78.33%
85.42%

⫺14.79
⫺7.91
⫺3.3
⫺0.02

13.81
8.18
14.86
7.52

⫺17.79
⫺20.76
2.92
⫺0.74

73.35
18.68
36.94
18.85

⫺161.56, 125.98
⫺57.39, 15.86
⫺69.48, 75.33
⫺37.69, 36.22

16.13%
19.35%
16.13%
48.39%

38.71%
58.06%
51.61%
87.10%

⫺14.59
⫺4.57
0.83

2.39
8.08
7.97

⫺38.20
⫺13.67
3.28

18.43
18.25
17.26

⫺74.33, ⫺2.07
⫺49.44, 22.09
⫺30.55, 37.12

0.00%
45.16%
38.71%

32.26%
77.42%
96.77%

⫺27.80
⫺6.49
⫺13.03
4.82

17.85
13.67
24.10
12.40

⫺30.28
⫺7.54
⫺12.63
7.44

15.31
15.08
25.57
16.13

⫺60.30, ⫺0.26
⫺37.10, 22.01
⫺62.75, 37.47
⫺24.19, 39.07

10.81%
29.73%
24.32%
50.00%

39.19%
78.38%
59.46%
90.54%

⫺11.58
5.56
7.91

3.59
9.77
10.29

⫺23.09
7.90
11.68

17.80
13.53
14.70

⫺57.98, 11.80
⫺18.62, 34.43
⫺17.14, 40.50

18.92%
45.95%
44.59%

71.62%
89.19%
94.59%

⫺41.97
⫺8.50
⫺51.19
9.22

31.25
24.68
58.57
21.93

⫺29.87
⫺5.75
⫺31.42
10.0.32

18.31
18.77
30.01
19.54

⫺65.76, 6.01
⫺42.53, 31.03
⫺90.24, 27.39
⫺27.97, 48.61

11.76%
51.76%
15.29%
27.06%

47.06%
84.71%
40.00%
87.06%

4.91
14.69
10.97

5.24
17.95
20.56

4.10
15.02
11.73

4.48
16.80
18.76

⫺4.68, 12.89
⫺17.90, 47.94
⫺25.03, 48.50

90.59%
29.41%
30.59%

100.00%
90.59%
89.41%

⫺26.69
12.61
⫺52.77
34.53

37.93
31.20
73.57
28.25

⫺14.46
9.96
⫺23.89
26.71

17.63
18.10
27.90
18.61

⫺49.02, 20.10
⫺25.52, 45.44
⫺78.58, 30.79
⫺9.76, 63.19

34.57%
29.63%
14.81%
11.11%

80.25%
92.59%
50.62%
65.43%

8.92
43.01
35.69

7.00
20.16
21.24

6.31
32.93
26.98

4.48
14.99
15.65

⫺2.47, 15.09
3.53, 62.33
⫺3.69, 57.66

93.83%
6.17%
14.81%

100.00%
55.56%
72.84%
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Table 4. (Continued)

Bias
GFR ⱖ150 ml/min per 1.73 m2
equations with serum cystatin C
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin C
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq

SD of
Bias

Relative
Bias (%)

Accuracy (%)
Within

Relative
SD of
Bias (%)

95% Limit of
Agreement
for Relative
SD of Bias

10%

30%

⫺24.4
17.02
⫺61.31
39.89

44.78
37.02
89.86
33.50

⫺11.77
12.56
⫺24.68
29.01

19.27
19.86
30.09
20.43

⫺49.55, 26.01
⫺26.38, 51.50
⫺83.67, 34.30
⫺11.02, 69.06

36.59%
29.27%
12.20%
4.88%

85.37%
90.24%
51.22%
60.98%

6.33
49.75
41.00

9.02
21.81
23.81

4.07
35.66
28.99

5.26
15.26
16.39

⫺6.24, 14.40
5.74, 65.57
⫺3.13, 61.13

97.56%
2.44%
12.20%

100.00%
46.34%
70.73%

Bias ⫽ mean difference between 99mTc DTPA GFR and cystatin C eGFR; relative bias ⫽ mean % difference ⫽ 关100 ⫻ (99mTc DTPA
GFR ⫺ cystatin C eGFR)/99mTc DTPA GFR兴; SD of the bias ⫽ precision (an increase in the SD of bias means a decrease in the
precision); SD of the relative bias ⫽ relative precision; accuracy ⫽ percentage of cystatin C eGFR values within 10% and 30% of
the respective 99mTc DTPA GFR measurements. eGFR, estimated GFR; 99mTc DTPA, technetium-99m– diethylene-triamine
penta-acetic acid.

calculations that improved the equation’s AUC and correlation coefficient.
The reasons for variation in the accuracy with GFR remain poorly understood. The GFR categories were similar
in regard to the distribution of age, gender, obese, and
adolescent patients. The size and charge on cystatin C
molecule cannot explain the pattern. We noticed that the
equations derived from the patients with low GFR levels
(CKiD equation, mean GFR 44 ⫾ 15 ml/min per 1.73 m2;
Zappitelli equation, mean GFR 74 ⫾ 36 ml/min per 1.73
m2) performed better at a low GFR, whereas the equations
derived from normal or high GFR levels (Bouvet equation,
mean GFR 95 ml/min per 1.73 m2; Filler equation, mean
GFR 103 ⫾ 41 ml/min per 1.73 m2; Grubb equation, median GFR 113 ml/min per 1.73 m2 for age ⬍14 years and 99
for 14 to ⬍18 years) performed better at corresponding
high GFR. On the basis of this observation, we speculate
that an equation has a better diagnostic accuracy at the
GFR that is close to that of the study sample used for
deriving the equations.
The findings from this study should be interpreted in the
light of its limitations. It is important to note that the
Bökenkamp, CKiD, and Grubb equations measured cystatin C with turbidometry (PETIA), whereas the Bouvet,
Filler, and Zappitelli used a nephelometric immunoassay
(PENIA). Different assays may explain some of the variability but cannot fully explain the trend of diagnostic
accuracy within a particular equation. We analyzed the
CKiD equation with the model that did not include urea
because of the unavailability of urea levels for all patients.
In the original study, the R2 of 69.4% and % eGFR of 84%
within 30% of the measured GFR was a bit lower than
corresponding values of 75.2% and 87.7% with urea (11).
The inclusion of urea would have improved the performance of the equation to some extent; however, it cannot
explain the change in the diagnostic accuracy of the equation at different GFR levels. Because of a small number, we
could not separately analyze for GFR ⬍30 ml/min per 1.73

m2. None of the included patients had significant edema to
induce GFR overestimation from a tracer dilution (30).
With different accuracy tests, the choice of an accuracy
test should depend upon the intended objective. If the
purpose is to categorize a measured GFR into a CKD
category, the sensitivity and specificity of an equation can
provide the required information. However, an accurate
prediction of the measured GFR becomes clinically relevant if the goal is to monitor the trend of GFR longitudinally. Given the variability in the performance of various
equations with GFR, an ideal equation that can be applied
to all remains a challenge. Short of an individualized approach based on GFR levels, further research on refining
the equations should focus on data pooling, ensuring the
quality of the gold-standard method, and choosing a mathematical model that best resembles the naturally occurring
decline of isotope measurements in the time concentration
curve. Ideally, nonlinear mixed pharmacokinetic models
that adjust for extracorporeal volume, gender, ethnicity,
and age as well as selection of an appropriate model with
the number of compartments should be utilized. Perhaps
the Baysian approach for the WinNonLin derived GFR
calculations employed by Bouvet et al. can maximize the
quality of the gold-standard method of measuring GFR (8).
Standardized calibration and uniformity in using cystatin
C assays can improve the prediction by cystatin C equations (31).

Conclusions
We conclude that the diagnostic accuracy of various
cystatin C equations varies at different GFR levels. Further
studies should focus on refining the equations to improve
their consistency across all GFR ranges.

Disclosures
None.
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Table 5. Diagnostic accuracy (area under the ROC curves, sensitivity, and specificity) of cystatin C estimated GFR estimated by
various cystatin C equations across different GFR categories (ml/min per 1.73 m2)

GFR⬍60 ml/min per 1.73 m2
equations with serum cystatin
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq
GFR⬍90 ml/min per 1.73 m2
equations with serum cystatin
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq
GFR ⱖ 135 ml/min per 1.73 m2
equations with serum cystatin
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq
GFR ⱖ 150 ml/min per 1.73 m2
equations with serum cystatin
Bökenkamp et al.
Filler and Lepage
Grubb et al.
Zapitelli-CysEq
equations with serum cystatin
and serum creatinine
Bouvet et al.
CKiD
Zapitelli-CysCrEq

Area under the ROC
Curve (AUC) (95% CI)

SEM

Sensitivity (%)

Specificity (%)

0.99 (0.96 to 0.99)
0.99 (0.96 to 0.99)
0.98 (0.95 to 0.99)
0.99 (0.97 to 0.99)

0.005
0.005
0.008
0.004

83.87 (66.3 to 94.5)
83.87 (66.3 to 94.5)
80.65 (62.5 to 92.5)
96.77 (83.3 to 99.9)

100.00 (98.3 to 100.0)
100.00 (98.3 to 100.0)
98.09 (95.2 to 99.5)
94.74 (90.8 to 97.3)

1.00 (0.98 to 1.00)
0.98 (0.95 to 0.99)
0.98 (0.96 to 0.99)

0.000
0.013
0.008

64.52 (45.4 to 80.8)
90.32 (74.2 to 98.0)
93.55 (78.6 to 99.2)

100.00 (98.3 to 100.0)
97.13 (93.9 to 98.9)
90.43 (85.6 to 94.1)

0.97 (0.94 to 0.99)
0.97 (0.94 to 0.99)
0.97 (0.93 to 0.98)
0.97 (0.94 to 0.98)

0.011
0.011
0.010
0.012

60.81 (48.8 to 72.0)
89.19 (79.8 to 95.2)
78.38 (67.3 to 87.1)
98.65 (92.7 to 100.0)

100.00 (97.8 to 100.0)
95.78 (91.5 to 98.3)
98.19 (94.8 to 99.6)
81.33 (74.6 to 86.9)

1.00 (0.98 to 1.00)
0.97 (0.94 to 0.99)
0.98 (0.95 to 0.99)

0.000
0.007
0.006

86.49 (76.5 to 93.3)
100.00 (95.1 to 100)
98.65 (92.7 to 100.0)

100.00 (97.8 to 100.0)
77.11 (70.0 to 83.3)
79.52 (72.6 to 85.4)

0.85 (0.80 to 0.89)
0.85 (0.80 to 0.89)
0.83 (0.78 to 0.88)
0.83 (0.78 to 0.88)

0.023
0.023
0.025
0.025

97.47 (91.2 to 99.7)
48.10 (36.7 to 59.6)
88.61 (79.5 to 94.7)
17.72 (10.0 to 27.9)

60.87 (52.9 to 68.5)
86.34 (80.0 to 91.2)
63.35 (55.4 to 70.8)
95.65 (91.2 to 98.2)

1.00 (0.98 to 1.00)
0.84 (0.79 to 0.89)
0.85 (0.80 to 0.89)

0.000
0.024
0.023

58.02 (46.5 to 68.9)
12.66 (6.2 to 22.0)
20.25 (12.0 to 30.8)

100.00 (97.7 to 100.0)
96.89 (92.9 to 99.0)
96.27 (92.1 to 98.6)

0.84 (0.79 to 0.89)
0.84 (0.79 to 0.89)
0.84 (0.78 to 0.88)
0.83(0.78 to 0.88)

0.025
0.025
0.026
0.026

97.37 (86.2 to 99.9)
39.47 (24.0 to 56.6)
89.47 (75.2 to 97.1)
13.16 (4.4 to 28.1)

65.84 (58.9 to 72.4)
91.58 (86.9 to 95.0)
59.90 (52.8 to 66.7)
98.02 (95.0 to 99.5)

1.00 (0.98 to 1.00)
0.84 (0.79 to 0.88)
0.85(0.80 to 0.89)

0.000
0.028
0.026

51.22 (35.1 to 67.1)
7.89 (1.7 to 21.4)
15.79 (6.0 to 31.3)

100.00 (98.2 to 100.0)
99.50 (97.3 to 100.0)
98.51 (95.7 to 99.7)

C

C

C

C

C

C

C

C

ROC, receiver operating characteristic; AUC, area under curve; CI, confidence interval; CKiD, chronic kidney disease in children.
P ⬍ 0.001 for all AUC estimations.
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